Press Release

Glenmark Receives Approval From the Regulator (DCGI) to Conduct Clinical Trials in India on Favipiravir Antiviral Tablets for COVID-19 Patients

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *